Editor's Choice – The ENGAGE Registry Ten Year Outcomes with the Endurant Stent Graft System for Endovascular Abdominal Aortic Aneurysm Repair
European Journal of Vascular and Endovascular Surgery · 2026
DOI: 10.1016/j.ejvs.2025.06.070 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2026. Verfasst von Hence J M Verhagen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands. Electronic address: h.verhagen@erasmusmc.nl. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Endovascular Procedures, Stents, Blood Vessel Prosthesis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian College of Midwives, Medtronic Inc.
Abstract (Originalsprache)
OBJECTIVE: Long term performance of endovascular aneurysm repair has not been well studied. The Endurant Stent Graft Natural Selection Global Post-market Registry (ENGAGE) observational, multicentre, non-randomised, prospective global registry was used to assess long term outcomes in patients treated with the Endurant stent graft system (Medtronic, Santa Rosa, CA, USA). METHODS: Inclusion criteria were minimal and included patients who fell outside of the instructions for use guidance. Exclusion criteria were high probability of non-adherence to follow up requirements, or concurrent participation in another trial that could confound results. Clinical and imaging data were collected continuously to evaluate treatment efficacy through ten years. RESULTS: There were 1 263 patients enrolled in the ENGAGE registry, of whom 390 re-consented for follow up from more than five through ten years and constituted the extended follow up (FU) cohort. The other 873 patients made up the non-extended FU cohort. For the extended FU cohort from more than five through ten years, Kaplan-Meier rates with 95% confidence intervals (95% CIs) were 97.3% (95% CI 95.5 - 99.1%) for freedom from site reported all cause mortality, 75.7% (95% CI 70.4 - 81.0%) for freedom from Clinical Event Committee adjudicated aneurysm related mortality, and 99.4% (95% CI 98.6 - 100%) for freedom from conversion to open surgical repair. From zero through to ten years, these rates were 96.2% (95% CI 94.0 - 98.4%) for aneurysm rupture and 71.4% (95% CI 66.3 - 76.5%) for aneurysm related re-interventions. For the extended FU cohort in the first five years, freedom estimates were 99.2% (95% CI 98.4 - 100%) for aneurysm rupture and 83.6% (95% CI 79.9 - 87.3%) for aneurysm related re-interventions. Late re-interventions (n = 72) were associated with type Ia endoleaks (18/72), type II endoleaks (18/72), and type Ib endoleaks (16/72). At ten years, 64.1% of patients exhibited sac regression, 19.2% were sac stable, and 16.8% had sac expansion. CONCLUSION: This is the first study to report long term outcomes in a real world, global cohort of patients with abdominal aortic aneurysm treated with the Endurant stent graft. Overall, long term efficacy and durability were observed in patients who survived beyond five years post-enrolment in the ENGAGE registry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands. Electronic address: h.verhagen@erasmusmc.nl.
- Department of Vascular Surgery, Catharina Hospital, Eindhoven, the Netherlands.
- Department of Vascular Surgery, Western University, London, Ontario, Canada.
- Multi-Modality Medical Imaging (M3I) Group, TechMed Centre, University of Twente, Enschede, the Netherlands; Department of Vascular Surgery, Rijnstate, Arnhem, the Netherlands.
- Department of Surgery, Zuyderland Medical Center, Heerlen, the Netherlands; Faculty of Science and Engineering, Maastricht University, Maastricht, the Netherlands.
- Department of Vascular Surgery, Ghent University Hospital, Ghent, Belgium.
Förderung
- Australian College of Midwives
- Medtronic Inc
Zitieren
APA
Verhagen, H. J. M., Teijink, J. A. W., Power, A. H., Reijnen, M. M. P. J., Bouwman, L. H., Vermassen, F. E. G., Riambau, V., Erhart, P., Ling, S., Cuypers, P. W. M., Loftus, I. M., & ENGAGE Investigators (2026). Editor's Choice – The ENGAGE Registry Ten Year Outcomes with the Endurant Stent Graft System for Endovascular Abdominal Aortic Aneurysm Repair. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2025.06.070
Vancouver
Verhagen HJM, Teijink JAW, Power AH, Reijnen MMPJ, Bouwman LH, Vermassen FEG, et al. Editor's Choice – The ENGAGE Registry Ten Year Outcomes with the Endurant Stent Graft System for Endovascular Abdominal Aortic Aneurysm Repair. European Journal of Vascular and Endovascular Surgery. 2026. doi:10.1016/j.ejvs.2025.06.070
BibTeX
@article{Verhagen2026,
author = {Verhagen, Hence J M and Teijink, Joep A W and Power, Adam H and Reijnen, Michel M P J and Bouwman, Lee H and Vermassen, Frank E G and Riambau, Vincente and Erhart, Philipp and Ling, Shuqiong and Cuypers, Philippe W M and Loftus, Ian M and ENGAGE Investigators, ENGAGE Investigators},
title = {Editor's Choice – The ENGAGE Registry Ten Year Outcomes with the Endurant Stent Graft System for Endovascular Abdominal Aortic Aneurysm Repair},
journal = {European Journal of Vascular and Endovascular Surgery},
year = {2026},
doi = {10.1016/j.ejvs.2025.06.070}
}
EUVIMED